Ryan Gill, MD

Pathologist

Dr. Ryan Gill is a surgical pathologist at UCSF Medical Center who specializes in the diagnosis and evaluation of adult and pediatric liver disease, liver transplantation, inflammatory bowel disease, and liver and gastrointestinal tract neoplasia and lymphoma. In his research, he focuses on advancing the diagnosis, prognosis and treatment options for patients with liver and gastrointestinal diseases.

Gill received an M.D. and Ph.D. at the University of Kansas in Kansas City, Kan. He then completed a combined anatomic and clinical pathology residency, followed by fellowships in hematopathology and liver and gastrointestinal pathology at UCSF. Gill is a member of several professional organizations, including the Alpha Omega Alpha Medical Honor Society, College of American Pathologists, Hans Popper Hepatopathology Society, the Rodger C. Haggitt Gastrointestinal Pathology Society and the United States and Canadian Academy of Pathology. He has received several awards, including the American Society for Investigative Pathology Merit Award and the UCSF Department of Laboratory Medicine Research Award. Gill has published numerous book chapters on surgical pathology and lectures around the country. He is an associate professor of Clinical Pathology at UCSF.

Academic Title

Associate Professor

More about Ryan Gill

Education

University of Kansas School of Medicine 2005

Residencies

UCSF Medical Center 2009

Fellowships

UCSF Medical Center 2010

Selected Research and Publications

  1. Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis. Clin Gastroenterol Hepatol. 2018 Mar 14.
  2. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 Apr; 67(4):1628-1630.
  3. Hameed B, Terrault NA, Gill RM, Loomba R, Chalasani N, Hoofnagle JH, Van Natta ML. Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2018 Mar; 47(5):645-656.
  4. Choi WT, Brown I, Ushiku T, Yozu M, Setia N, Srivastava A, Johncilla M, Pai RK, Gill RM, Fukayama M, Misdraji J, Lauwers GY. Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases. Histopathology. 2017 Dec 26.
  5. Fernandez A, Conrad M, Gill RM, Choi WT, Kumar V, Behr S. Solitary fibrous tumor in the abdomen and pelvis: A case series with radiological findings and treatment recommendations. Clin Imaging. 2018 Mar - Apr; 48:48-54.
  6. Wen KW, Gill RM. Immature Terminal Deoxynucleotidyl Transferase Positive B Cells are Detected in a Subset of Adult and Pediatric Liver Biopsies. Appl Immunohistochem Mol Morphol. 2017 Sep 29.
  7. Graham RP, Yeh MM, Lam-Himlin D, Roberts LR, Terracciano L, Cruise MW, Greipp PT, Zreik RT, Jain D, Zaid N, Salaria SN, Jin L, Wang X, Rustin JG, Kerr SE, Sukov WR, Solomon DA, Kakar S, Waterhouse E, Gill RM, Ferrell L, Alves VA, Nart D, Yilmaz F, Roessler S, Longerich T, Schirmacher P, Torbenson MS. Molecular testing for the clinical diagnosis of fibrolamellar carcinoma. Mod Pathol. 2018 Jan; 31(1):141-149.
  8. Perito ER, Ajmera V, Bass NM, Rosenthal P, Lavine JE, Schwimmer JB, Yates KP, Diehl AM, Molleston JP, Murray KF, Scheimann A, Gill R, Glidden D, Aouizerat B. Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2017 Sep; 1(7):609-622.
  9. Chen B, Wei W, Ma L, Yang B, Gill RM, Chua MS, Butte AJ, So S. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells InVitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Gastroenterology. 2017 06; 152(8):2022-2036.
  10. Tsai JH, Ferrell LD, Tan V, Yeh MM, Sarkar M, Gill RM. Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition. Mod Pathol. 2017 Jun; 30(6):834-842.
  11. Geha R, Peters M, Gill RM, Dhaliwal G. Histology Rings True. N Engl J Med. 2017 03 02; 376(9):869-874.
  12. Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection. Am J Surg Pathol. 2017 Mar; 41(3):365-373.
  13. Bean GR, Joseph NM, Gill RM, Folpe AL, Horvai AE, Umetsu SE. Recurrent GNAQ mutations in anastomosing hemangiomas. Mod Pathol. 2017 May; 30(5):722-727.
  14. Giard JM, Decker KA, Lai JC, Gill RM, Logan AC, Fix OK. Acute Liver Failure Secondary to Hemophagocytic Lymphohistiocytosis during Pregnancy. ACG Case Rep J. 2016 Aug; 3(4):e162.
  15. Ajmera V, Perito ER, Bass NM, Terrault NA, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat BE. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology. 2017 01; 65(1):65-77.
  16. Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Aliment Pharmacol Ther. 2016 12; 44(11-12):1253-1264.
  17. Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, Barlow SE, Vos MB, Karpen SJ, Molleston JP, Whitington PF, Rosenthal P, Jain AK, Murray KF, Brunt EM, Kleiner DE, Van Natta ML, Clark JM, Tonascia J, Doo E. In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. Gastroenterology. 2016 12; 151(6):1141-1154.e9.
  18. Yang JD, Abdelmalek MF, Guy CD, Gill RM, Lavine JE, Yates K, Klair J, Terrault NA, Clark JM, Unalp-Arida A, Diehl AM, Suzuki A. Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of NonalcoholicSteatohepatitis. Clin Gastroenterol Hepatol. 2017 01; 15(1):127-131.e2.
  19. Hale G, Liu X, Hu J, Xu Z, Che L, Solomon D, Tsokos C, Shafizadeh N, Chen X, Gill R, Kakar S. Correlation of exon 3 -catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Mod Pathol. 2016 Nov; 29(11):1370-1380.
  20. Tsokos CG, Krings G, Yilmaz F, Ferrell LD, Gill RM. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma. Hum Pathol. 2016 11; 57:61-67.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.